InMode (INMD) Return on Capital Employed (2019 - 2026)
InMode (INMD) posted Return on Capital Employed of 11.72% for Q1 2026, down 6.72% sequentially from 12.56% in Q4 2025, and down 465.0% YoY from 3.21% in Q1 2025.
InMode (INMD) Return on Capital Employed (2019 - 2026) Analysis & Trends
InMode has reported Return on Capital Employed for 8 years, with the latest figure at 11.72% in Q1 2026.
- Quarterly Return on Capital Employed fell 465.0% year-over-year to 11.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.72% (down 465.0% YoY) and the FY2025 annual result came in at 12.11%, down 281.0% from the prior year.
- Return on Capital Employed retreated to 11.72% in Q1 2026 per INMD's latest filing, from 12.56% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 42.07% in Q2 2022 and troughed at 11.72% in Q1 2026.
- A 5-year average of 25.23% and a median of 22.06% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2024: Return on Capital Employed jumped 822 bps in 2022, then plunged 1680 bps in 2024.
- Over 5 years, Return on Capital Employed stood at 37.35% in 2022, then slipped by 29 bps to 26.45% in 2023, then sank by 42 bps to 15.31% in 2024, then decreased by 18 bps to 12.56% in 2025, then decreased by 7 bps to 11.72% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 11.72%, 12.56%, and 13.36% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | InMode | 912.51 Mn | 497.35 Mn | 71.52 Mn | 10.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.72% |
| Dec 31, 2025 | 12.56% |
| Sep 30, 2025 | 13.36% |
| Jun 30, 2025 | 17.91% |
| Mar 31, 2025 | 16.36% |
| Dec 31, 2024 | 15.31% |
| Sep 30, 2024 | 17.74% |
| Jun 30, 2024 | 17.23% |
| Mar 31, 2024 | 22.06% |
| Dec 31, 2023 | 26.45% |
| Sep 30, 2023 | 30.05% |
| Jun 30, 2023 | 34.03% |
| Mar 31, 2023 | 34.13% |
| Dec 31, 2022 | 37.35% |
| Sep 30, 2022 | 38.95% |
| Jun 30, 2022 | 42.07% |
| Mar 31, 2022 | 41.67% |
| Dec 31, 2021 | 40.72% |
| Sep 30, 2021 | 41.16% |
| Jun 30, 2021 | 39.95% |